Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.

Evgeniia Korotchenko; Viktoria Schießl; Sandra Scheiblhofer; Mario Schubert; Elfriede Dall; Isabella A Joubert; Helen Strandt; Theresa Neuper; Muamera Sarajlic; Renate Bauer; Mark Geppert; David Joedicke; Sabrina Wildner; Susanne Schaller; Stephan Winkler; Gabriele Gadermaier; Jutta Horejs-Hoeck; Richard Weiss

doi:10.1111/all.14481

Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.

Evgeniia Korotchenko (First author), Viktoria Schießl, Sandra Scheiblhofer, Mario Schubert, Elfriede Dall, Isabella A Joubert, Helen Strandt, Theresa Neuper, Muamera Sarajlic, Renate Bauer, Mark Geppert, David Joedicke, Sabrina Wildner, Susanne Schaller, Stephan Winkler, Gabriele Gadermaier, Jutta Horejs-Hoeck, Richard Weiss

Research output: Contribution to journal › Original Article › peer-review

18 Citations (Web of Science)

Original language	English
Pages (from-to)	210-222
Journal	ALLERGY
Volume	76
Issue number	1
DOIs	https://doi.org/10.1111/all.14481
Publication status	Published - 2021

Keywords

TARGETING DENDRITIC CELLS
REGULATORY T-CELLS
GM-CSF
TRANSCUTANEOUS IMMUNOTHERAPY
DECTIN-1
RECEPTOR
VACCINATION
EXPRESSION
SAFETY
MACROPHAGES

Access to Document

10.1111/all.14481

Cite this

Korotchenko, E., Schießl, V., Scheiblhofer, S., Schubert, M., Dall, E., Joubert, I. A., Strandt, H., Neuper, T., Sarajlic, M., Bauer, R., Geppert, M., Joedicke, D., Wildner, S., Schaller, S., Winkler, S., Gadermaier, G., Horejs-Hoeck, J., & Weiss, R. (2021). Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma. ALLERGY , 76(1), 210-222. https://doi.org/10.1111/all.14481

Korotchenko, Evgeniia ; Schießl, Viktoria ; Scheiblhofer, Sandra et al. / Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma. In: ALLERGY 2021 ; Vol. 76, No. 1. pp. 210-222.

@article{c23fe92486534fdaacd1bde96dd3ff95,

title = "Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.",

keywords = "TARGETING DENDRITIC CELLS, REGULATORY T-CELLS, GM-CSF, TRANSCUTANEOUS IMMUNOTHERAPY, DECTIN-1, RECEPTOR, VACCINATION, EXPRESSION, SAFETY, MACROPHAGES",

author = "Evgeniia Korotchenko and Viktoria Schie{\ss}l and Sandra Scheiblhofer and Mario Schubert and Elfriede Dall and Joubert, {Isabella A} and Helen Strandt and Theresa Neuper and Muamera Sarajlic and Renate Bauer and Mark Geppert and David Joedicke and Sabrina Wildner and Susanne Schaller and Stephan Winkler and Gabriele Gadermaier and Jutta Horejs-Hoeck and Richard Weiss",

year = "2021",

doi = "10.1111/all.14481",

language = "English",

volume = "76",

pages = "210--222",

journal = "ALLERGY ",

issn = "0105-4538",

number = "1",

}

Korotchenko, E, Schießl, V, Scheiblhofer, S, Schubert, M, Dall, E, Joubert, IA, Strandt, H, Neuper, T, Sarajlic, M, Bauer, R, Geppert, M, Joedicke, D, Wildner, S, Schaller, S, Winkler, S, Gadermaier, G, Horejs-Hoeck, J & Weiss, R 2021, 'Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.', ALLERGY , vol. 76, no. 1, pp. 210-222. https://doi.org/10.1111/all.14481

Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma. / Korotchenko, Evgeniia (First author); Schießl, Viktoria; Scheiblhofer, Sandra et al.
In: ALLERGY , Vol. 76, No. 1, 2021, p. 210-222.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma.

AU - Korotchenko, Evgeniia

AU - Schießl, Viktoria

AU - Scheiblhofer, Sandra

AU - Schubert, Mario

AU - Dall, Elfriede

AU - Joubert, Isabella A

AU - Strandt, Helen

AU - Neuper, Theresa

AU - Sarajlic, Muamera

AU - Bauer, Renate

AU - Geppert, Mark

AU - Joedicke, David

AU - Wildner, Sabrina

AU - Schaller, Susanne

AU - Winkler, Stephan

AU - Gadermaier, Gabriele

AU - Horejs-Hoeck, Jutta

AU - Weiss, Richard

PY - 2021

Y1 - 2021

KW - TARGETING DENDRITIC CELLS

KW - REGULATORY T-CELLS

KW - GM-CSF

KW - TRANSCUTANEOUS IMMUNOTHERAPY

KW - DECTIN-1

KW - RECEPTOR

KW - VACCINATION

KW - EXPRESSION

KW - SAFETY

KW - MACROPHAGES

U2 - 10.1111/all.14481

DO - 10.1111/all.14481

M3 - Original Article

C2 - 32621318

SN - 0105-4538

VL - 76

SP - 210

EP - 222

JO - ALLERGY

JF - ALLERGY

IS - 1

ER -

Korotchenko E, Schießl V, Scheiblhofer S, Schubert M, Dall E, Joubert IA et al. Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma. ALLERGY . 2021;76(1):210-222. doi: 10.1111/all.14481